Close

Pfizer (PFE) Reports Prevenar 13 Met Primary, Secondary Objectives in CAPTA

March 12, 2014 6:39 AM EDT Send to a Friend
Pfizer Inc. (NYSE: PFE) presented detailed results of the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA), the landmark study of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login